Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 2.1 Membership Interest Purchase Agreement Dated October 31, 2018, by and Among G Medical Innovations USA, Inc., Telerhythmics, LLC, Digirad Imaging Solutions and Digirad Corporation
- 3.1 Amended and Restated Memorandum and Articles of Association of G Medical Innovations Holdings LTD. Currently In Effect
- 3.2 Amended and Restated Memorandum and Articles of Association of G Medical Innovations Holdings LTD. to Be Effective Upon the Closing of This Offering
- 10.1 Form of Indemnification Agreement
- 10.2 G Medical Innovations Holdings Global Equity Plan
- 10.2.1 G Medical Innovations Holdings LTD. - Israel Sub-plan
- 10.2.2 G Medical Innovations Holdings LTD. - U.S. Sub-plan
- 10.3 Form of Performance Rights Agreement
- 10.4 Software Licensing Agreement, Dated August 4, 2016, by and Between the Company and Mennen Medical LTD. (Exhibit a of This Exhibit 10.14 Includes an Unofficial English Translation of the Hebrew Original)
- 10.5 Collateral Agency Agreement, Dated October 29, 2018, by and Between the Company and Mef I, L.P
- 10.6 General Security Agreement, Dated October 29, 2018, by and Between the Company and Mef I, L.P
- 10.7 Convertible Securities Agreement, Dated October 29, 2018, by and Between the Company and Mef I, L.P
- 10.8 Amendment to Convertible Securities Agreement, Dated March 26, 2019, by and Between the Company and Mef I, L.P
- 10.9 Amendment to Convertible Securities Agreement, Dated August 15, 2019, by and Between the Company and Mef I, L.P
- 10.10 Amendment to Convertible Securities Agreement, Dated November 26, 2019, by and Between the Company and Mef I, L.P
- 10.11 Capital Commitment Agreement, Dated November 29, 2019 by and Between the Company, Gem Global Yield Fund LLC SCS and Gem Yield Bahamas LTD
- 10.12 Credit Line Agreement, Dated December 6, 2015, by and Between the Company and DR. Yacov Geva
- 10.13 Loan Agreement, Dated December 19, 2016, by and Between the Company and DR. Yacov Geva
- 10.14 Amendment to Loan Agreement, Dated February 26, 2017, by and Between the Company and DR. Yacov Geva
- 10.15 Loan Agreement, Dated October 1, 2018, by and Between the Company and DR. Yacov Geva
- 10.16 Deed of Termination, Settlement and Release, Dated February 2020, by and Between the Company, Mef I, L.P. and DR. Yacov Geva
- 10.17 Second Deed of Variation, Dated April 2020, by and Between the Company, Mef I, L.P. and DR. Yacov Geva
- 10.18 Summary Translation of Loan Agreement, Dated February 25, 2019, Between Bank Mizrahi and the Company
- 10.19 Provider Participation Agreement, Dated May 2019, by and Between the Company and Prime Health Services, Inc
- 10.20 Summary Translation of Lease Agreement, Dated February 2019, by and Between the Company and Ad Marom Assets and Initiation LTD
- 10.21 Distribution Agreement, Dated April 21, 2020, by and Between the Company and Home Service Solutions Pty LTD
- 10.22 Addendum to Distribution Agreement, Dated April 21, 2020, by and Between the Company and Home Service Solutions Pty LTD
- 10.23 Media and Marketing Services Agreement, Dated September 30, 2020, by and Between the Company and GRS, LLC
- 10.24 Provider Participation Agreement, Dated April 2019, by and Between the Company and Ancillary Care Services, Inc
- 10.25 Distribution Agreement, Dated April 20, 2020, by and Between the Company and Livecare Corp
- 10.26 Distribution Agreement, Dated April 2020, by and Between the Company and All County Health Care Inc
- 10.27 Securities Purchase Agreement Dated December 21, 2020, Between the Company and Alpha Capital Anstalt
- 10.28 Convertible Debenture Dated December 21, 2020 Issued by the Company to Alpha Capital Anstalt Under the Securities Purchase Agreement Dated December 21, 2020
- 10.29 Form of Warrant Issued by the Company to Alpha Capital Anstalt Under the Securities Purchase Agreement Dated As of December 21, 2020
- 10.30 Securities Purchase Agreement Dated February 17, 2021, Between the Company and Alpha Capital Anstalt
- 10.31 Convertible Debenture Dated February 21, 2021, Issued by the Company to Alpha Capital Anstalt Under the Securities Purchase Agreement Dated February 17, 2021
- 10.32 Form of Warrant Issued by the Company to Alpha Capital Anstalt Under the Securities Purchase Agreement Dated As of February 17, 2021
- 10.33 Controlled Placement Deed, Dated September 5, 2018, by and Between the Company and Acuity Capital Investment Management Pty LTD
- 10.34 Controlled Placement Deed Side Letter, Dated September 5, 2018, by and Between the Company and Acuity Capital Investment Management Pty LTD
- 10.35 Joint Venture Agreement, Dated May 22, 2017, by and Between the Company and Guangzhou Sino-israel Biotech Investment Fund (LLP)
- 21.1 List of Subsidiaries
- 23.1 Consent of Ziv Haft, a Member Firm of Bdo
- 99.1 Consent of Chanan Epstein As Director Nominee
- 99.2 Registrant's Representation Pursuant to Requirements of Form 20-F, Item 8.A.4
Associated filings
- 28 Jun 21 424B4 Prospectus supplement with pricing info
- 25 Jun 21 EFFECT Notice of effectiveness
- 15 Jun 21 F-1/A Registration statement (foreign) (amended)
- 11 Jun 21 FWP Free writing prospectus
- 9 Jun 21 F-1/A Registration statement (foreign) (amended)
- 22 Apr 21 F-1/A Registration statement (foreign) (amended)
- 22 Mar 21 FWP Free writing prospectus
- 22 Mar 21 F-1/A Registration statement (foreign) (amended)
-
4 Mar 21 F-1 Registration statement (foreign)
GMVDF similar filings
- 9 Jun 21 Registration statement (foreign) (amended)
- 22 Apr 21 Registration statement (foreign) (amended)
- 22 Mar 21 Registration statement (foreign) (amended)
- 4 Mar 21 Registration statement (foreign)
- 29 Oct 20 Registration statement (foreign) (amended)
- 28 Oct 20 Registration statement (foreign) (amended)
- 22 Oct 20 Registration statement (foreign) (amended)
Filing view
External links
Exhibit 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We hereby consent to the use in this Registration Statement on Form F-1 of G Medical Innovations Holdings Ltd. of our report dated July 16, 2020, except for footnote 23.I, which is dated January 13, 2021, which is contained in the Prospectus. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Registration Statement.
/s/ Ziv Haft | |
Ziv Haft | |
Certified Public Accountants (Isr.) | |
BDO Member Firm |
Tel Aviv, Israel
March 2, 2021